239 related articles for article (PubMed ID: 23839199)
1. Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma.
Ramírez SP; Carvajal AC; Salazar JC; Arroyave G; Flórez AM; Echeverry HF
J Drugs Dermatol; 2013 Jun; 12(6):e106-10. PubMed ID: 23839199
[TBL] [Abstract][Full Text] [Related]
2. Treatment of mild to moderate facial melasma with the Lumixyl topical brightening system.
Hantash BM; Jimenez F
J Drugs Dermatol; 2012 May; 11(5):660-2. PubMed ID: 22527440
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
Guevara IL; Pandya AG
Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
[TBL] [Abstract][Full Text] [Related]
4. Open-label evaluation of the skin-brightening efficacy of a skin-brightening system using decapeptide-12.
Kassim AT; Hussain M; Goldberg DJ
J Cosmet Laser Ther; 2012 Apr; 14(2):117-21. PubMed ID: 22401652
[TBL] [Abstract][Full Text] [Related]
5. Tolerability and efficacy of a novel formulation in the treatment of melasma.
Guevara IL; Werlinger KD; Pandya AG
J Drugs Dermatol; 2010 Mar; 9(3):215-8. PubMed ID: 20232581
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
Monheit GD; Dreher F
J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
[TBL] [Abstract][Full Text] [Related]
7. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
Dayal S; Sahu P; Dua R
J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
[TBL] [Abstract][Full Text] [Related]
8. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
9. Rapid treatment of mild acne with a novel skin care system containing 1% salicylic acid, 10% buffered glycolic acid, and botanical ingredients.
Bhatia AC; Jimenez F
J Drugs Dermatol; 2014 Jun; 13(6):678-83. PubMed ID: 24918557
[TBL] [Abstract][Full Text] [Related]
10. Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma.
Sarkar R; Garg V; Bansal S; Sethi S; Gupta C
Dermatol Surg; 2016 Mar; 42(3):384-91. PubMed ID: 26859648
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma.
Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE
J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
Bruce S
J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma.
Erbil H; Sezer E; Taştan B; Arca E; Kurumlu Z
J Dermatol; 2007 Jan; 34(1):25-30. PubMed ID: 17204097
[TBL] [Abstract][Full Text] [Related]
15. Novel skin brightener used as monotherapy for moderate melasma in skin of color.
Grimes PE
J Drugs Dermatol; 2014 Mar; 13(3):364-6. PubMed ID: 24595584
[TBL] [Abstract][Full Text] [Related]
16. A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma.
Hantash BM; Jimenez F
J Drugs Dermatol; 2009 Aug; 8(8):732-5. PubMed ID: 19663110
[TBL] [Abstract][Full Text] [Related]
17. A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma.
Crocco EI; Veasey JV; Boin MF; Lellis RF; Alves RO
Cutis; 2015 Nov; 96(5):337-42. PubMed ID: 26682557
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma.
Farshi S
J Cosmet Dermatol; 2011 Dec; 10(4):282-7. PubMed ID: 22151936
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma.
Gold MH; Biron J
J Cosmet Dermatol; 2011 Sep; 10(3):189-96. PubMed ID: 21896130
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients.
Sarkar R; Bhalla M; Kanwar AJ
Dermatology; 2002; 205(3):249-54. PubMed ID: 12399672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
